• Oracle buys Cerner for $28 billion ($95 per share).
  • UBS Group is appealing to the Supreme Court in the tax evasion case of rich French people.
  • Eliott and Vista are preparing a bid for Citrix, according to Bloomberg.
  • Tesla has lost the 35% it gained since signing a giant deal with Hertz.
  • Rocket Internet's management is considering a buyout at EUR 35 a share.
  • DKSH strengthens its position in specialty ingredients with the acquisition of HTBA.
  • Micron recovers 6.8% after its quarterly results.
  • BKW acquires UMB.
  • Stadler Rail takes control of German BBR.
  • A Complaint was filed against Walmart for illegal disposal of hazardous waste.
  • Sandoz (Novartis) files US application for Herceptin biosimilar.
  • FWD abandons its bid to go public in New York.
  • Nike reported better-than-expected quarterly revenue and profit on strong demand in North America and said it was confident that problems affecting supply chains would improve in its upcoming annual fiscal year.
  • Stephane Bancel, Moderna's chief executive, said Tuesday that his group does not expect to encounter problems developing a booster dose of its COVID-19 vaccine targeting the Omicron variant of the coronavirus and that clinical trials could begin in early 2022.
  • Aridis Pharmaceuticals announced it had developed a monoclonal antibody cocktail against COVID-19 that retains efficacy against the Omicron variant of the coronavirus.
  • Nordstrom said it was considering a spin-off of its Nordstrom Rack discount store subsidiary, according to Bloomberg.
  • General Mills fell 5.2% in premarket trading after lower-than-expected quarterly results linked in part to higher raw material, transportation and labor costs.

Major earnings releases: General Mills, FactSet, BlackBerry...